VR Logo

Piramal Enterprises Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1947

Chairman: Ajay Piramal

Managing Director: --

Group: Piramal Ajay

Listing: NSE: PEL, BSE: 500302

Headquarters: Mumbai, Maharashtra

Website: www.piramal.com

Key Facts

Market cap: R 32,301.59 Cr

Revenue (TTM): R 14,423.08 Cr

Earnings (TTM): R -468.42 Cr

Cash: R 7,721.51 Cr

Total Debt: R 42,054.54 Cr

Promoters' ownership: 46.06%

Liquidity: High

52 Week range: R 606.85 - 2,040.09

Face value: R2.00

Shares outstanding: 22,55,38,290

10 Years Aggregate:

  • CFO: -47,677.91 Cr
  • EBITDA: 24,234.92 Cr
  • Net Profit: 22,283.47 Cr

Stock Performance

Time Period Piramal Enterprises S&P BSE Healthcare S&P BSE Mid Cap
YTD-6.0524.01-10.45
1 month34.473.256.38
3 months55.6812.7518.95
1 Year-24.5128.69-7.86
3 Years-20.324.54-4.00
5 Years9.10-0.733.98
10 Years11.1611.246.13
As on 13-Jul-2020
Year Piramal Enterprises S&P BSE Mid Cap S&P BSE Healthcare
2019-34.84-3.05-3.55
2018-16.36-13.31-5.89
201776.4648.130.49
201660.887.97-12.88
201520.607.4315.06
201451.5754.6947.43
20135.86-5.7322.55